AS-OCT Guided Treatment of Diffuse CSCC

NCT03515954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2019-01-02

No results posted yet for this study

Summary

A prospective study was performed on 8 eyes of 8 patients who underwent amniotic membrane graft after diffuse conjunctival squamous cell neoplasia excision followed by topical mitomycin C 0.04% eye drop between March 2014 and January 2018.

Conditions

  • Conjunctival Neoplasms

Interventions

PROCEDURE

Treatment of diffuse ocular surface squamous neoplasia

Excision of the conjunctival tumour was done.Amniotic membrane was secured into conjunctival defects. Postoperative topical MMC 0.04% was given. Response to treatment was monitored clinically and by AS-OCT.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2018-01-31
Completion
2018-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03515954 on ClinicalTrials.gov